Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Brand/Generic Settlements: DoJ Asks Second Circuit To Review Its Standards

This article was originally published in The Pink Sheet Daily

Executive Summary

If the court reverses its position, it would intensify the existing splits between the circuits and could prompt the Supreme Court to finally take up the issue.

You may also be interested in...



Legal News, In Brief: Copaxone, AngioMax, Cipro, Botox, OxyContin

Teva Wins Ruling On Copaxone Patents

Legal News, In Brief: Copaxone, AngioMax, Cipro, Botox, OxyContin

Teva Wins Ruling On Copaxone Patents

Patent Settlements: 2nd Circuit Okays Bayer's Cipro Deal But Doesn't Want To

While the U.S. Court of Appeals for the Second Circuit found that a reverse settlement agreement involving Bayer's antibiotic Cipro did not violate antitrust laws, it invited the plaintiffs to seek a reexamination of the case by the full court

Topics

UsernamePublicRestriction

Register

ID004339

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel